{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:31:46Z","timestamp":1793385106406,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jad.2026.122398","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:02:10Z","timestamp":1787266930000},"page":"122398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Remission outcomes with bupropion versus selective serotonin reuptake inhibitors in major depressive disorder with comorbid obesity: A propensity-matched cohort analysis"],"prefix":"10.1016","volume":"414","author":[{"given":"Farah","family":"Khorassani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Prunean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Espejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.122398_bb0005","article-title":"Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-MOODINFLAME consortium","volume":"10","author":"Arteaga-Henr\u00edquez","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122398_bb0010","author":"Depressive disorder (depression)"},{"key":"10.1016\/j.jad.2026.122398_bb0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pmip.2016.12.001","article-title":"Personalizing antidepressant choice by sex, body mass index, and symptom profile: an iSPOT-D report","volume":"1-2","author":"Green","year":"2017","journal-title":"Personalized Medicine in Psychiatry."},{"key":"10.1016\/j.jad.2026.122398_bb0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jad.2021.03.032","article-title":"Is obesity a determinant of success with pharmacological treatment for depression? A systematic review, meta-analysis and meta-regression","volume":"287","author":"Grigolon","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122398_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbi.2021.05.010","article-title":"High-fat diet induces neuroinflammation and reduces the serotonergic response to escitalopram in the hippocampus of obese rats","volume":"96","author":"Hersey","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"30","key":"10.1016\/j.jad.2026.122398_bb0030","doi-asserted-by":"crossref","first-page":"6564","DOI":"10.1523\/JNEUROSCI.2618-20.2021","article-title":"Inflammation-induced histamine impairs the capacity of escitalopram to increase hippocampal extracellular serotonin","volume":"41","author":"Hersey","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jad.2026.122398_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jad.2018.02.089","article-title":"Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: findings from CO-MED trial","volume":"234","author":"Jha","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.jad.2026.122398_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157240","article-title":"Prospective associations between depression and obesity for adolescent males and females- a systematic review and Meta-analysis of longitudinal studies","volume":"11","author":"Mannan","year":"2016","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.jad.2026.122398_bb0045","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S2215-0366(25)00193-2","article-title":"Clinical management of major depressive disorder with comorbid obesity","volume":"12","author":"Opel","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.122398_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.173073","article-title":"Bupropion monotherapy alters neurotrophic and inflammatory markers in patients of major depressive disorder","volume":"200","author":"Tafseer","year":"2021","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726012516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726012516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:50:45Z","timestamp":1793382645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726012516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":10,"alternative-id":["S0165032726012516"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122398","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remission outcomes with bupropion versus selective serotonin reuptake inhibitors in major depressive disorder with comorbid obesity: A propensity-matched cohort analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122398"}}